KENAY Pylopass Lactobacillus reuteri (60 caps)
Sign in to see your own prices.
- EAN
- 5900672154818
- In stock
- In stock
- Weight
- 0.14 kg
DESCRIPTION:
The strain Lactobacillus reuteri was isolated from tens of thousands of other bacterial strains. In this painstaking process, a unique type of bacteria was separated out, showing the strongest activity against the H. pylori strain. Pylopass® withstands the low pH of the stomach thanks to a specific survival mechanism that is not affected by hydrochloric acid. It does not require controlled temperature during transport and storage.
Pylopass® production process:
Microbial fermentation is one of the specialities of Novozymes (the manufacturer of Pylopass®). Pylopass® is produced through the fermentation of a patented strain of L. reuteri under controlled conditions in order to achieve peak aggregation capability. After fermentation, the cells are harvested, embedded in a matrix and spray-dried at a low temperature.
INGREDIENTS:
Lactobacillus reuteri; capsule: hydroxypropyl methylcellulose.
| Ingredients | 1 capsule | |
Lactobacillus reuteri DSM 17648 /Pylopass®/ | 230mg | 2,3 x 10^10 CFU* |
*CFU – Colony Forming Unit – a unit forming a bacterial colony
Pylopass® is a registered trademark of Novozymes Berlin GmbH
DIRECTIONS FOR USE:
One capsule per day, after breakfast.
CONTRAINDICATIONS:
Do not exceed the recommended daily intake. Food supplements must not be used as a substitute for a varied diet. This product should not be used by pregnant or breastfeeding women, or by children under 3 years of age.
STORAGE:
Store in a closed package at room temperature, out of reach of small children.
Ingredients
Lactobacillus reuteri DSM 17648 /Pylopass®/ 230 mg (2.3 x 10^10 CFU*). Capsule shell: hydroxypropyl methylcellulose. *CFU – Colony Forming Unit. Pylopass® is a registered trademark of Novozymes Berlin GmbH. Vcaps® is a trademark of Lonza or its affiliates.
Recommended retail prices in the feed are information only. You set your own selling price.